https://www.selleckchem.com/pr....oducts/filgotinib.ht
The aim of this work was to explore the novel and promising biomarkers for the diagnosis and prognosis of cervical cancer patients. The secretome of primary cervical tissues was extracted and then determined by the LC-MS/MS assay. The level of screened targets was confirmed using the RT-PCR and ELISA in cervical cancer tissue samples. The median expression level of certain targets was used as a cutoff value to divide the patients into 2 groups, and then the patients were followed up. The predictive abilities of the targets on the pro
Aimer
Commentaire
Partagez
